The weekly litigation news digest is live. Subscribe now

IP Verse

Modified Oncolytic Virus

Patent No. EP3400293 (titled "Modified Oncolytic Virus") was filed by Replimune on Jan 9, 2017. The application was issued on Jul 12, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MARGARET DIXONJun 7, 2021MEWBURN ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3400293

REPLIMUNE
Application Number
EP17701910A
Filing Date
Jan 9, 2017
Status
Patent Maintained As Amended
Jun 9, 2023
Publication Date
Jul 12, 2023
External Links
Slate, EP3400293B2, Google Patents